Lactobacillus rhamnosus LRa05 and Improved Glycemia

• Multi-Strain Probiotics BLa80, LRa05, and BBr60 Modulate Inflammation, Bile Acids, and Gut Microbiota in Type 2 Diabetes: A Randomized Controlled Trial.

  • 2026-04
  • RCT · n = 80
  • Food science & nutrition 14(4)
  • • Sijia Zhu
    • Yan Qiao
    • Wenjing He
    • Yaojie Xiao
    • Guiqin Song
    • Kang Liu
    • Shuguang Fang

  • PubMed: 41971606
  • DOI: 10.1002/fsn3.71735

  4 Insights on

  • Improved Glycemia

  • High evidence

  The probiotic group also exhibited significant reductions in total glycated hemoglobin (GHb) and fasting plasma glucose (FPG, p < 0.05).

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes

• Precision Microbiome Modulation: Exploring Lactobacillus spp. as A Targeted Strategy for Type 2 Diabetes Management.

  • 2026-03-04
  • Review
  • Current nutrition reports 15(1)
  • • Ann Sze Cheah
    • Ji Wei Tan
    • Faizul Jaafar
    • Wendy Wai Yeng Yeo

  • PubMed: 41779301
  • DOI: 10.1007/s13668-026-00739-3

  4 Insights on

  • Improved Glycemia

  • Low evidence

  Lactobacillus spp. supplementation alleviates insulin resistance in T2DM by modulating glucose metabolism and transport, exerting anti-inflammatory and anti-oxidative effects as well as restructuring gut microbiota.

  Effect

  Beneficial

  Effect size

  Moderate

• Correction to "Lactobacillus rhamnosus LRa05 on glycemic control and gut microbiota in patients with type 2 diabetes".

  • 2025-11-15
  • World journal of diabetes 16(11)
  • • Lin Geng
    • Ting-Ting Sun
    • Wen-Bo Xia
    • Ying Qin
    • Di Huo
    • Guang-Jin Qu

  • PubMed: 41278440
  • DOI: 10.4239/wjd.v16.i11.114013

  1 Insight on

  • Improved Glycemia

  • Low evidence

  The correction notice refers to the article "Lactobacillus rhamnosus LRa05 on glycemic control and gut microbiota in patients with type 2 diabetes," indicating the study assessed glycemic control outcomes in people with type 2 diabetes.

  Effect

  Beneficial

  Effect size

  Moderate